ConductScience.org, home

Paper32010567

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).

Mandaliya H and 3 others. Transl Lung Cancer Res, 2019. Cited by 335 papers, by iCite.

Cite this record

ConductScience Library. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Papers, record 32010567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32010567

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
PubMed
Journal
Transl Lung Cancer Res
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
335
iCite
Relative citation ratio, by iCite
15.6
iCite
Revised in PubMed
2022-04-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mandaliya HHiren
2Jones MMark
3Oldmeadow CChristopher
4Nordman IIIna Ic

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112966420Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.Br J Cancer2003https://conductscience.org/library/papers/12966420PubMed
224927957Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet.Med Oncol2014https://conductscience.org/library/papers/24927957PubMed
326205001Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.Sci Rep2015https://conductscience.org/library/papers/26205001PubMed
422855161Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer.Clin Transl Oncol2012https://conductscience.org/library/papers/22855161PubMed
528929586Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017.Asia Pac J Clin Oncol2018https://conductscience.org/library/papers/28929586PubMed
611229684Inflammation and cancer: back to Virchow?Lancet2001https://conductscience.org/library/papers/11229684PubMed
715346996Greater risks of chemotherapy toxicity in elderly patients with cancer.J Support Oncol2003https://conductscience.org/library/papers/15346996PubMed
812490959Inflammation and cancer.Nature2002https://conductscience.org/library/papers/12490959PubMed
929356383Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?Clin Respir J2018https://conductscience.org/library/papers/29356383PubMed
1023530866Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.BMC Cancer2013https://conductscience.org/library/papers/23530866PubMed
1127025911Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.Sci Rep2016https://conductscience.org/library/papers/27025911PubMed
1230620402Cancer statistics, 2019.CA Cancer J Clin2019https://conductscience.org/library/papers/30620402PubMed
1326779364Geriatric oncology: problems with under-treatment within this population.Cancer Biol Med2015https://conductscience.org/library/papers/26779364PubMed
1418214060Long-term survivors after chemotherapy in advanced non-small cell lung cancer.Anticancer Res2007https://conductscience.org/library/papers/18214060PubMed
1526955285Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis.Onco Targets Ther2016https://conductscience.org/library/papers/26955285PubMed

Download CSV of references

Cited by282

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 335 citations.

PMIDTitleJournalYearIn PapersSource
42958623Systemic Inflammatory Indices and Hearing Loss in U.S. Adults Aged 40-85 Years: A Serial Cross-Sectional Study 1999-2020.Immun Inflamm Dis2026https://conductscience.org/library/papers/42958623PubMed
42930159Baseline and Dynamic Clinical-Laboratory Risk Models for Early Progression or Death During PD-(L)1 Blockade in Advanced NSCLC: Development and Internal Validation.Curr Oncol2026https://conductscience.org/library/papers/42930159PubMed
42501018Diagnostic Management of Asymptomatic Pulmonary Embolism: A Predictive Model Integrating Inflammatory Markers and Clinical Characteristics in Patients With Deep Vein Thrombosis.Clin Appl Thromb Hemost2026https://conductscience.org/library/papers/42501018PubMed
42488103Levels of chronic systemic inflammation markers in patients with multi-stages of esophageal and gastric lesions.Front Oncol2026https://conductscience.org/library/papers/42488103PubMed
42445435Association between pan-immune-inflammation value and prognosis in lung cancer patients: a systematic review and meta-analysis.Transl Cancer Res2026https://conductscience.org/library/papers/42445435PubMed
42433165Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/42433165PubMed
42428338Association of Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) With Molecular Subtypes of Breast Cancer.Iran J Pathol2026https://conductscience.org/library/papers/42428338PubMed
42273683Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients.Front Immunol2026https://conductscience.org/library/papers/42273683PubMed
42261002Peripheral blood inflammatory indices and their association with hospitalization status in acute exacerbation of chronic obstructive pulmonary disease: A retrospective observational study.J Int Med Res2026https://conductscience.org/library/papers/42261002PubMed
42145953Correlations between inflammatory biomarkers and clinicopathological features in surgically resected thymic epithelial tumors: implications for preoperative diagnosis.PeerJ2026https://conductscience.org/library/papers/42145953PubMed
42125693The impact of inflammation on the incidence of different pathological types of lung cancer: the Kailuan study.Front Oncol2026https://conductscience.org/library/papers/42125693PubMed
42022321Associations of three immune inflammatory markers with the risk of brain metastasis from lung cancer: a systematic review and meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42022321PubMed
42014920Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single-Center Study.Cancer Med2026https://conductscience.org/library/papers/42014920PubMed
41979751Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy.Discov Oncol2026https://conductscience.org/library/papers/41979751PubMed
41977057The Role of Nutritional and Inflammatory Indices in Predicting Prognosis in Older Adults Undergoing Radiotherapy for Lung Cancer: NIRT-LC Study.J Clin Med2026https://conductscience.org/library/papers/41977057PubMed
41939190Prognostic value of the C-reactive protein-albumin-lymphocyte (CALLY) index in surgically treated non-small cell lung cancer.Front Nutr2026https://conductscience.org/library/papers/41939190PubMed
41901549Prognostic Value of Systemic Inflammation Markers (NLR and Haemoglobin) in Non-Small Cell Lung Cancer: Survival Analysis from a Real-World Single-Centre Cohort Study.Medicina (Kaunas)2026https://conductscience.org/library/papers/41901549PubMed
41899290Monocyte-to-Lymphocyte Ratio as New Prognostic Factor in Patients with Medullary Thyroid Carcinoma.J Clin Med2026https://conductscience.org/library/papers/41899290PubMed
41803760The prognostic value analysis of PIV, PLR, LMR, NPR, and NLR in hilar cholangiocarcinoma.BMC Cancer2026https://conductscience.org/library/papers/41803760PubMed
41798482Prognostic Significance of Bone Marrow Computed Tomography Attenuation in Patients With Non-small Cell Lung Cancer Without Curative Surgery.Cureus2026https://conductscience.org/library/papers/41798482PubMed

See all 282 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32010567

GET https://conductscience.org/api/papers/v1/32010567/cited_by?page=2